Benzthiazide

Benzthiazide

SCHEMBL26258

NS(=O)(=O)c1cc2c(cc1Cl)NC(CSCc1ccccc1)=NS2(=O)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC12A3

The experimentally established mechanism targets of Benzthiazide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
CYP3A4 P08684 3/20 1.00
CYP2C9 P11712 3/20 1.00
TSHR P16473 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
KDM4E B2RXH2 2/20 1.00
MEN1 O00255 1/20 1.00
NR1I2 O75469 1/20 1.00
ABCB11 O95342 1/20 1.00
ADRA2A P08913 1/20 1.00
CYP2D6 P10635 1/20 1.00
PKM P14618 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
KMT2A Q03164 1/20 1.00
CYP1A2 P05177 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CA1 P00915 9/20 0.46
LMNA P02545 3/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzthiazide SCHEMBL29495263 1.00 ALDH1A1 (1.00) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL26257 0.77 ALDH1A1 (0.63) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL6546528 0.76 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL7102453 0.76 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL345215 0.76 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL9517821 0.76 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL7217920 0.76 ALDH1A1 (0.62) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
SCHEMBL3863724 0.76 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
Benzthiazide SCHEMBL1276519 0.75 ALDH1A1 (0.60) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2
SCHEMBL3864106 0.74 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP2C9TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9643 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090360-A1 FUSED PYRIMIDINE COMPOUNDS FOR TREATMENT OF TINNITUS, HEARING LOSS, AND MENIERE'S DISEASE OVID THERAPEUTICS INC. (US) 2026-04-30 WO claimed
US-20260108529-A1 FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, AGE-RELATED HEARING LOSS, AND MENIERE'S DISEASE OVID THERAPEUTICS INC (US) 2026-04-23 US claimed
EP-4722714-A1 SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) Korea Institute of Science and Technology (KR) 2026-04-08 EP claimed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
WO-2024028324-A1 MOLECULES FOR THE PREVENTION AND TREATMENT OF NEUROMUSCULAR DISORDERS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2024-02-08 WO claimed
US-20240002935-A1 GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS GENETICURE INC. 2024-01-04 US claimed
US-20230266330-A1 EXOSOMAL TUMOR BIOMARKERS AND COLLECTIONS THEREOF CORNELL UNIVERSITY 2023-08-24 US claimed
CN-115787323-A Low ammonia nitrogen printing process 华纺股份有限公司 2023-03-14 CN claimed
EP-4132653-A1 GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS Geneticure Inc. (US) 2023-02-15 EP claimed
CN-115400697-A Automatic control method and system for double-layer structure carbon-three-liquid phase hydrogenation reactor and hydrogenation reactor 中国石油化工股份有限公司 2022-11-29 CN claimed
EP-0000561-B1 WATER-SOLUBLE, RETICULATED NITROGENOUS CONDENSATION PRODUCTS AND THEIR USE BASF Aktiengesellschaft (DE) 1981-10-14 EP claimed
US-4285947-A DIURETICS, HYPOTENSIVES INTERX RESEARCH CORPORATION (US) 1981-08-25 US claimed
EP-0032725-A1 Novel aldehyde adducts of triamterene and a pharmaceutical composition containing the same MERCK & CO. INC. (US) 1981-07-29 EP claimed
US-4238485-A 1,2,5-THIADIAZOLE DERIVATIVE, THIAZIDE DIURETIC, HYPOTENSIVE AGENTS MERCK & CO., INC. (US) 1980-12-09 US claimed
US-4217347-A MERCAPTOALKYL ALKANOYLPROLINES AND A DIURETIC E. R. SQUIBB & SONS, INC. (US) 1980-08-12 US claimed
EP-0007097-A1 Tensio-active polypodes, process for their preparation and compositions containing them L'OREAL (FR) 1980-01-23 EP claimed
US-4178374-A SUBSTITUTED 1,2,5-THIADIAZOLE B-ADRENERGIC BLOCKING AGENT, PYRAZINE AND/OR THIAZIDE DIURETIC, TREATMENT OF HYPERTENSION MERCK & CO., INC. (US) 1979-12-11 US claimed
EP-0004863-A1 Cosmetic and pharmaceutical compositions, tensioactive cyclic polyethers and methods for preparing them L'OREAL (FR) 1979-10-31 EP claimed
US-4022894-A Stable solution of benzthiazide (3-[benzythiol methyl]-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide) suitable for parenteral administration and process of preparation FAINBERG SAMUEL M 1977-05-10 US claimed
US-3963674-A Process for the production of halogenated carboxylic acid amides CHEMISCHE FABRIK KALK GMBH (DT) 1976-06-15 US claimed